Brief: CellBxHealth Announces Discontinuation Of FDA License For Parsortix System
13/02/2026 07:13
Feb 13 (Reuters) - Cellbxhealth PLC CLBX.L: CELLBXHEALTH PLC - DISCONTINUES FDA LICENSE FOR PARSORTIX SYSTEM Source text: ID:nRSM8324Sa Further company coverage: CLBX.L ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cellbxhealth
See all newsBrief: Cellbxhealth Anticipates FY2027 Revenues Of £3 Million-£4 Million
Brief: Cellbxhealth Enters Master Services Agreement With Swiss Biotech
Master Services Agreement with Swiss biotech co
Q3 Trading Update and FY 2026 Outlook
Brief: Cellbxhealth Signs New Statement Of Work With US-Based Pharma Company